Literature DB >> 15291940

Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood.

Knut Evanger1, Olav H Haugen, Agot Irgens, Leif Aanderud, Einar Thorsen.   

Abstract

PURPOSE: The aim of this study was to quantify ocular refractive changes after a standard hyperbaric oxygen (HBO) treatment protocol and to characterize the time period of recovery. PATIENTS AND METHODS: Hyperbaric oxygen therapy was given for 90 min daily at a pressure of 240 kPa for 21 days. Oxygen was administered to 20 patients using an oronasal mask and to 12 patients using a hood. Follow-up examinations were carried out 2-4 days after treatment, and thereafter regularly for up to 10 weeks in both groups. Refraction was assessed automatically and by the monocular subjective refraction method. A subgroup of nine of the 20 patients to whom oxygen was administered by an oronasal mask underwent a separate eye examination, which included crystalline lens opacity measurements and LOCS III gradings.
RESULTS: In the patients given oxygen by mask, there was a significant myopic shift in the mean spherical equivalent, which was largest 2-4 days after treatment. The shift was - 0.55 +/- 0.40 D in the right eye and - 0.53 +/- 0.42 D in the left eye. In the patients given oxygen by hood, the largest shift was observed after 12-16 days, and was - 1.06 +/- 0.52 D in the right eye and - 1.10 +/- 0.57 D in the left eye. The refractive changes returned to baseline 6 weeks and 10 weeks after HBO treatment, respectively. No significant changes in crystalline lens transparency were revealed.
CONCLUSIONS: The myopic shift after HBO therapy recovers within 10 weeks and may be more pronounced when patients are given oxygen using a hood compared with using an oronasal mask.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291940     DOI: 10.1111/j.1395-3907.2004.00290.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  14 in total

Review 1.  Adjunctive hyperbaric oxygen for necrotizing fasciitis.

Authors:  Denny Levett; Michael H Bennett; Ian Millar
Journal:  Cochrane Database Syst Rev       Date:  2015-01-15

Review 2.  Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified.

Authors:  Marvin Heyboer; Deepali Sharma; William Santiago; Norman McCulloch
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-06-01       Impact factor: 4.730

3.  Mitochondrial DNA haplogroup distribution in Chaoshanese with and without myopia.

Authors:  Qin Wang; Panfeng Wang; Shiqiang Li; Xueshan Xiao; Xiaoyun Jia; Xiangming Guo; Qing-Peng Kong; Yong-Gang Yao; Qingjiong Zhang
Journal:  Mol Vis       Date:  2010-02-26       Impact factor: 2.367

4.  The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial.

Authors:  Michael H Bennett; Cheng Fb Hui; Hooi G See; Kwan L Au-Yeung; Christopher Tan; Stephanie Watson
Journal:  Diving Hyperb Med       Date:  2019-12-20       Impact factor: 0.887

Review 5.  Vitreoretinal influences on lens function and cataract.

Authors:  David C Beebe; Nancy M Holekamp; Carla Siegfried; Ying-Bo Shui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

Review 6.  Oxidative damage and the prevention of age-related cataracts.

Authors:  David C Beebe; Nancy M Holekamp; Ying-Bo Shui
Journal:  Ophthalmic Res       Date:  2010-09-09       Impact factor: 2.892

7.  Oxidative responses induced by pharmacologic vitreolysis and/or long-term hyperoxia treatment in rat lenses.

Authors:  Qi Li; Hong Yan; Tian-Bing Ding; Jing Han; Ying-Bo Shui; David C Beebe
Journal:  Curr Eye Res       Date:  2013-03-27       Impact factor: 2.424

8.  Identification of H2O2 induced oxidative stress associated microRNAs in HLE-B3 cells and their clinical relevance to the progression of age-related nuclear cataract.

Authors:  Song Wang; Chenjun Guo; Mengsi Yu; Xiaona Ning; Bo Yan; Jing Zhao; Angang Yang; Hong Yan
Journal:  BMC Ophthalmol       Date:  2018-04-13       Impact factor: 2.209

Review 9.  Hyperbaric oxygen therapy in chronic pain management.

Authors:  Senol Yildiz; Gunalp Uzun; M Zeki Kiralp
Journal:  Curr Pain Headache Rep       Date:  2006-04

Review 10.  Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy.

Authors:  Charles McMonnies
Journal:  J Optom       Date:  2017-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.